AI Business Bigger Than The Smartphone Business?

Key takeaways

Potential U.S. government investment in Intel reflects a shift towards more active industrial policy in response to global competition.
Meta's AI chatbots faced scrutiny over content policies, sparking conversations about ethical AI regulation.
Foxconn's pivot to AI products indicates a significant change in revenue streams for traditional tech manufacturers.
Apple's workaround for blood oxygen monitoring illustrates the complexities of navigating tech and medical device regulations.
Woop's pushback against the FDA highlights the ongoing struggle to delineate between medical and wellness technologies.

Summary

The U.S. Government and Intel Stake Discussions

The podcast discusses potential talks between the Trump administration and Intel about the U.S. government possibly taking a financial stake in the company. This deal could support Intel's plans for a factory hub in Ohio, intended to be a major chip-making facility. Although the talks are still in a fluid state, the initiative underscores a growing trend of U.S. government engagement in key industries, particularly regarding national security and technological competitiveness.

Provocative Behavior of Meta's AI Bots

In another segment, the podcast reviews a controversial internal Meta document that allowed AI chatbots to engage in provocative conversations, including inappropriate interactions with children. Following backlash, some of these policies were retracted. The discussion covers the ethical implications of AI's capability to generate sensitive content and the potential for regulatory scrutiny, as lawmakers call for inquiries into Meta's practices.

Foxconn's Shift to AI Business

The podcast highlights Foxconn's AI server business growth, which has reportedly outpaced its iPhone assembly revenues for the first time. With a predicted surge in AI server revenue, Foxconn is positioning itself as a leading player in cloud and networking products, suggesting a transformative shift within the tech industry away from traditional consumer electronics.

Apple's Blood Oxygen Monitoring Return

The episode also features an update on Apple’s Watch Series 9 and Ultra 2, which reintroduces blood oxygen monitoring by utilizing the paired iPhone for data processing. This move circumvents previous legal restrictions regarding the feature while embroiling Apple in ongoing disputes with medical device competitor Massimo.

Woop and the FDA Standoff

Finally, the podcast mentions Woop's refusal to disable its blood pressure tracking tool despite an FDA request, reflecting ongoing industry tensions surrounding the regulation of health-related technology and fitness devices.

Weekend Longreads Suggestions

Listener suggestions for weekend reads include a New York Times piece discussing how AI data centers are affecting electricity costs, and another article on Wall Street's sudden embrace of cryptocurrency.

Show notes

Will the US government take a stake in Intel? Why was Meta letting spicy conversation happen with their AI bots? What does it mean if Foxconn’s AI business is now bigger than its gadget assembly business? And of course, the Weekend Longreads Suggestions.

Links:

Trump Administration Said to Discuss Taking Stake in Intel (Bloomberg)

Meta’s AI rules have let bots hold ‘sensual’ chats with kids, offer false medical info (Reuters)

Forget Foxconn the iPhone factory. AI’s made it a server-slinger first and foremost (The Register)

Apple returns blood oxygen monitoring to the latest Apple Watches (The Verge)

Whoop Refuses to Pull Blood Pressure Tool After FDA Warning (Bloomberg)

Weekend Longreads Suggestions:

Big Tech’s A.I. Data Centers Are Driving Up Electricity Bills for Everyone (NYTimes)

Behind Wall Street’s Abrupt Flip on Crypto (NYTimes)